BioRem Inc. (TSXV: BRM)
Canada
· Delayed Price · Currency is CAD
2.960
+0.090 (3.14%)
Jan 21, 2025, 3:11 PM EST
BioRem Revenue
BioRem had revenue of 14.89M CAD in the quarter ending September 30, 2024, with 170.19% growth. This brings the company's revenue in the last twelve months to 40.31M, up 68.88% year-over-year. In the year 2023, BioRem had annual revenue of 25.17M, down -12.81%.
Revenue (ttm)
40.31M
Revenue Growth
+68.88%
P/S Ratio
1.12
Revenue / Employee
1.19M
Employees
34
Market Cap
46.26M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 25.17M | -3.70M | -12.81% |
Dec 31, 2022 | 28.86M | 4.38M | 17.91% |
Dec 31, 2021 | 24.48M | 102.65K | 0.42% |
Dec 31, 2020 | 24.38M | 3.73M | 18.05% |
Dec 31, 2019 | 20.65M | -3.68M | -15.14% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Thomson Reuters | 9.68B |
Canadian Pacific Kansas City | 14.45B |
Canadian National Railway Company | 17.16B |
WSP Global | 15.23B |
GFL Environmental | 7.76B |
TFI International | 11.20B |
AtkinsRéalis Group | 9.36B |
Stantec | 5.63B |
BioRem News
- 2 months ago - Biorem Reports Record Quarterly Revenues and Earnings, - $14.9 Million of Revenues in the Quarter and Quarterly EPS of $0.14 - Benzinga
- 8 months ago - BIOREM Reports Strong First Quarter Financial Results and Continued Growth in Order Backlog - PRNewsWire